Stroke Management Market Size Grows at a CAGR of 7.09%

Introduction

Straits Research released its highly anticipated report, “Global Stroke Management Market Size & Outlook, 2026-2034”. According to the study, the global market size is valued at USD 4.38 billion in 2025 and is anticipated to grow to USD 8.09 billion by 2034, growing at a CAGR of 7.09% from 2026-2034.

Market Dynamics

The global stroke management market is expanding rapidly, driven by the growing incidence of strokes. In addition, rising cases of hypertension, diabetes, and sedentary lifestyles are significantly increasing the patient pool. Technological advancements in diagnostics, minimally invasive treatments, and rehabilitation techniques are further accelerating growth. Minimally invasive stroke procedures, such as mechanical thrombectomy and endovascular interventions, are gaining widespread adoption in hospitals and specialized stroke centers due to faster recovery times and improved outcomes, making them a new standard of care. Furthermore, the growing investment in artificial intelligence-powered imaging tools which are helping clinicians detect strokes earlier and improve decision-making for timely intervention.

However, the shortage of skilled neurologists and interventional radiologists in many regions limits access to advanced treatments. Additionally, high procedure costs and uneven reimbursement coverage in some countries make it difficult for patients to afford specialized care. These challenges are slowing adoption in lower and middle-income regions.

On the other hand, the increasing adoption of telestroke services is creating significant opportunities for market growth. For instance, the Centers for Medicare & Medicaid Services expanded telestroke reimbursement policies in 2025, improving access to specialized care in underserved areas in the U.S. Together, these advancements, along with supportive policies, are shaping a favourable environment for further innovation and expansion in the global stroke management market.

Market Highlights

• Type: The diagnostic segment dominated the market with a revenue share of 47.61% in 2025.
• Stroke Type: The ischemic stroke segment is estimated to grow at the fastest pace with a CAGR of 8.03% owing to the high prevalence of ischemic strokes globally and the increasing adoption of advanced treatment.
• Regional Insights: North America dominated the market with more than 40% of market share in 2025, owing to the increasing prevalence of haemorrhagic stroke.

Competitive Players

1. Merck & Co. Inc
2. Koninklijke Philips N.V.
3. Bristol-Myers Squibb Company
4. Heuron Co., Ltd., iSchemaView, Inc.
5. Aidoc
6. METHINKS
7. VasSol Inc.
8. GE Healthcare
9. Abbott Laboratories
10. Siemens AG
11. Boston Scientific Corporation
12. Viz.ai, Inc.
13. JLK
14. Penumbra, Inc.
15. Stryker Corporation
16. Acandis GmbH
17. Qure.ai.
18. Medtronic plc
19. Boehringer Ingelheim International GmbH
20. Brainomix
21. Others

Recent Developments

Segmentation

1. By Type (2026-2034)
   1. Diagnostic
      1. Magnetic Resonance Imaging
      2. Carotid Ultrasound
      3. Cerebral Angiography
      4. Electrocardiography
      5. Echocardiography
      6. Others
   2. Therapeutic
      1. Tissue Plasminogen Activator
      2. Anticoagulant
      3. Antiplatelet
      4. Antihypertensive
   3. Services
2. By Stroke Type (2026-2034)
   1. Ischemic Stroke
   2. Hemorrhagic Stroke